Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
MEDP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$302.01 - $459.77
Previous CloseN/A
Volume64.09K
Average Volume (3M)286.15K
Market Cap
$10.51B
Enterprise Value$10.07B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)27.3
Beta1.50
Next Earnings
Apr 28, 2025EPS Estimate
3.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)12.63
Shares Outstanding30,466,806
10 Day Avg. Volume416,334
30 Day Avg. Volume286,153
Standard Deviation0.12
R-Squared0.36
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.97
Price to Cash Flow (P/CF)13.70
P/FCF Ratio13.70
Enterprise Value/Market Cap0.96
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit15.34
Enterprise Value/Ebitda21.19
Forecast
1Y Price Target
$364.00Price Target Upside5.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Medpace Holdings News
PremiumCompany Announcements
Medpace Reports Revenue and Income Growth in 2024
PremiumCompany Announcements
Medpace Holdings: Navigating Growth and Challenges in 2025---
Bulls Say, Bears Say
Bulls Say
Cash FlowFree cash flow was strong, surpassing consensus estimates by a significant margin, indicating robust cash generation.
EarningsMEDP's earnings per share and EBITDA significantly exceeded analyst expectations, driven by better-than-expected cost management.
Revenue GuidanceDespite lowering revenue guidance for 2024, MEDP raised its earnings targets, highlighting effective productivity and cost-saving initiatives.
Bears Say
Biotech CompetitionMEDP noticed a level of heightened competition in the biotech space, presenting a challenge.
BookingsThe sequential decline in the book-to-bill ratio and a year-over-year decline in bookings are worse than investor expectations.
CancellationsMEDP experienced elevated cancellation rates in the quarter, which contributed to a decline in net bookings.
---
Ownership Overview
33.05% Insiders
25.66% Mutual Funds
1.04% Other Institutional Investors
19.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MEDP FAQ
What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was $302.01 and its highest was $459.77 in the past 12 months.
What is Medpace Holdings’s market cap?
Medpace Holdings’s market cap is $10.51B.
When is Medpace Holdings’s upcoming earnings report date?
Medpace Holdings’s upcoming earnings report date is Apr 28, 2025 which is in 65 days.
How were Medpace Holdings’s earnings last quarter?
Medpace Holdings released its earnings results on Feb 10, 2025. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $2.939 by $0.731.
Is Medpace Holdings overvalued?
According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
Does Medpace Holdings pay dividends?
Medpace Holdings does not currently pay dividends.
What is Medpace Holdings’s EPS estimate?
Medpace Holdings’s EPS estimate is 3.06.
How many shares outstanding does Medpace Holdings have?
Medpace Holdings has 30,466,806 shares outstanding.
What happened to Medpace Holdings’s price movement after its last earnings report?
Medpace Holdings reported an EPS of $3.67 in its last earnings report, beating expectations of $2.939. Following the earnings report the stock price went down -7.517%.
Which hedge fund is a major shareholder of Medpace Holdings?
Currently, no hedge funds are holding shares in MEDP
---
Medpace Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$364.00 (5.55% Upside)
$364.00 (5.55% Upside)
Blogger Sentiment
Bullish
MEDP Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 18.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.22%
12-Months-Change
Fundamentals
Return on Equity
58.41%
Trailing 12-Months
Asset Growth
26.80%
Trailing 12-Months
Company Description
Medpace Holdings
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
---
MEDP Company Deck
---
MEDP Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While the company achieved significant revenue and income growth in 2024, challenges such as a weak book-to-bill ratio, decrease in new business awards, and elevated cancellations pose concerns for 2025. The guidance for 2025 indicates a cautious outlook with flat to modest revenue growth expected.Read More>---
MEDP Revenue Breakdown
98.00% U.S.
2.00% Other
---
MEDP Stock 12 Month Forecast
Average Price Target
$364.00
▲(5.55% Upside)
Technical Analysis
Best Analysts Covering MEDP
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
-1.73%
reiterated a buy rating 11 days ago
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.73% per trade.
---